【结 构 式】 |
【分子编号】25541 【品名】methyl 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl]-2-chlorobenzoate 【CA登记号】 |
【 分 子 式 】C26H21ClN2O5 【 分 子 量 】476.91592 【元素组成】C 65.48% H 4.44% Cl 7.43% N 5.87% O 16.77% |
合成路线1
该中间体在本合成路线中的序号:(XI)Alternatively, pyrazole ester (IV) was hydrolyzed to carboxylic acid (IX) with NaOH in ethanol. Then, conversion of (IX) to acid chloride with SOCl2, followed by treatment with N,O-dimethylhydroxylamine provided N-methoxy amide (X). Subsequent coupling of (X) with bromide (V) in the presence of n-BuLi afforded ketone (VI). Oxazoline hydrolysis as before yielded acid (VII), which was protected as the methyl ester (XI) upon treatment with MeI and NaH. Ketalization of (XI) was carried out with trimethyl orthoformate in MeOH in the presence of p-TsOH yielding (XII), and the methyl ester function of (XII) was then hydrolyzed with NaOH to furnish acid (XIII). Finally, conversion to the target amide was effected by reaction with ammonia in the presence of EDC and HOBt.
【1】 Numata, H.; Okamoto, Y.; Shinoda, M.; Kobayashi, N.; Miyazawa, S.; Kawahara, T.; Shirota, H.; Nagakura, N.; Horizoe, T.; Abe, S.; Kobayashi, S.; Yamanaka, T. (Eisai Co., Ltd.); Pyrazole derivs. exhibiting anti-inflammatory and analgesic effects. JP 1998509140; WO 9614302 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IV) | 25534 | ethyl 1,5-bis(4-methoxyphenyl)-1H-pyrazole-3-carboxylate | C20H20N2O4 | 详情 | 详情 | |
(V) | 25535 | 2-(5-bromo-2-chlorophenyl)-4,4-dimethyl-4,5-dihydro-1,3-oxazole | C11H11BrClNO | 详情 | 详情 | |
(VI) | 25536 | [1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl][4-chloro-3-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)phenyl]methanone | C29H26ClN3O4 | 详情 | 详情 | |
(VII) | 25537 | 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl]-2-chlorobenzoic acid | C25H19ClN2O5 | 详情 | 详情 | |
(IX) | 25539 | 1,5-bis(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid | C18H16N2O4 | 详情 | 详情 | |
(X) | 25540 | N-methoxy-1,5-bis(4-methoxyphenyl)-N-methyl-1H-pyrazole-3-carboxamide | C20H21N3O4 | 详情 | 详情 | |
(XI) | 25541 | methyl 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl]-2-chlorobenzoate | C26H21ClN2O5 | 详情 | 详情 | |
(XII) | 25542 | methyl 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl](dimethoxy)methyl]-2-chlorobenzoate | C28H27ClN2O6 | 详情 | 详情 | |
(XIII) | 25543 | 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl](dimethoxy)methyl]-2-chlorobenzoic acid | C27H25ClN2O6 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(XI)An further synthetic route to the intermediate ketoester (XI) is depicted in Scheme 23794901c. Pyrazole aldehyde (XIV) was condensed with 5-bromo-2-chlorobenzoic acid (XV) in the presence of two equivalents of n--BuLi to afford carbinol (XVI). Subsequent reaction of (XVI) with (trimethylsilyl) diazomethane provided methyl ester (XVII). Then, oxidation of (XVII) with activated MnO2 in boiling 1,2-dichloroethane led to the required ketone (XI).
【1】 Numata, H.; Okamoto, Y.; Shinoda, M.; Kobayashi, N.; Miyazawa, S.; Kawahara, T.; Shirota, H.; Nagakura, N.; Horizoe, T.; Abe, S.; Kobayashi, S.; Yamanaka, T. (Eisai Co., Ltd.); Pyrazole derivs. exhibiting anti-inflammatory and analgesic effects. JP 1998509140; WO 9614302 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XI) | 25541 | methyl 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl]-2-chlorobenzoate | C26H21ClN2O5 | 详情 | 详情 | |
(XIV) | 25544 | 1,5-bis(4-methoxyphenyl)-1H-pyrazole-3-carbaldehyde | C18H16N2O3 | 详情 | 详情 | |
(XV) | 25545 | 5-bromo-2-chlorobenzoic acid | 21739-92-4 | C7H4BrClO2 | 详情 | 详情 |
(XVI) | 25546 | 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl](hydroxy)methyl]-2-chlorobenzoic acid | C25H21ClN2O5 | 详情 | 详情 | |
(XVII) | 25547 | methyl 5-[[1,5-bis(4-methoxyphenyl)-1H-pyrazol-3-yl](hydroxy)methyl]-2-chlorobenzoate | C26H23ClN2O5 | 详情 | 详情 |